Biotech

This Week's Barron's Roundup

Running down the list of the top 500 companies, and Matrix Advisors' David Katz shares his picks.

05/11/08 - 11:15 AM EDT

China Watch Mail Bag

Patrick Schultz offers his insight on American Oriental Bioengineering, a little-known China play.

05/10/08 - 08:59 AM EDT

Feuerstein's Biotech-Stock Mailbag

Elan's investor meeting proves exclusive; Medarex and the FDA, and more.

05/10/08 - 12:55 PM EDT

Biotech Earnings Review: Celgene, Biogen

An overview of how seven big biotech companies fared in the January-March quarter.

05/09/08 - 03:51 PM EDT

ASCO Abstract Preview: ImClone, Genentech

The American Society of Clinical Oncology, for the first time, is making research abstracts freely available to everyone ahead of the cancer drug confab. Here's a cheat sheet.

Article

Acquisition Charges Hit Celgene

But the biotech beats Wall Street estimates on an adjusted basis, when factoring out expenses related to Pharmion.

05/08/08 - 10:18 AM EDT

Article

FDA Panel Against Expansion of Cephalon's Fentora

The panel votes 17-3 against wider use of the pain drug.

05/06/08 - 05:36 PM EDT

Article

Onyx's Strong Quarter Bolsters New CEO

Tony Coles' tenure got off to the right start with strong earnings and meaningful financial guidance.

05/07/08 - 07:28 AM EDT

Article

Onyx Pharma Swings to Outsized Profit

The biotech company trounces Wall Street expectations for the first quarter on sales gains of Nexavar.

05/06/08 - 05:09 PM EDT

Article

Discovery Labs Holds Out Hope for Surfaxin

The stock Monday regains some of its sharp Friday losses on the company's positive response to FDA delays. But is the reaction overly optimistic?

05/05/08 - 11:53 AM EDT

Article

Feuerstein's Biotech-Stock Mailbag

Outlooks for SuperGen's Dacogen and Myriad Genetics' Flurizan; more Q&A on ImClone's Erbitux, and more.

05/03/08 - 11:10 AM EDT

Article

Biotech Notebook: Progenics, Wyeth

Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.

04/30/08 - 09:26 AM EDT

Article

Discovery Labs Awaits FDA Word on Surfaxin

A regulatory decision on the lung treatment could come May 1, but even with approval the biotech will have to work for every bit of upside.

04/29/08 - 02:02 PM EDT

Article

Biogen, Genentech's Rituxan Fails New Study

The drug failed to benefit patients with lupus, according to new late-stage study data.

04/29/08 - 10:12 AM EDT

Article

Vertex Hep C Drug Still Leads Schering

Data presented this weekend show telaprevir is the leader.

04/28/08 - 08:47 AM EDT

Article

Feuerstein's Biotech-Stock Mailbag

What to expect when ImClone presents the latest Erbitux data at ASCO in June.

04/26/08 - 09:57 AM EDT

Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Financial Tools

Financial Glossary

Enhance your investing education as you read articles on TheStreet.com. Look for the symbol throughout our site to look up items. Browse Glossary

Check a Rating

How does your portfolio rate? Enter a ticker below or go straight to our screeners: Stocks| ETFs| Funds